Zevra Therapeutics Inc (ZVRA)
7.20
+0.02
(+0.28%)
USD |
NASDAQ |
Oct 04, 16:00
7.195
0.00 (0.00%)
After-Hours: 20:00
Zevra Therapeutics Shareholders Equity (Annual): 61.86M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 61.86M |
December 31, 2022 | 75.12M |
December 31, 2021 | 127.12M |
December 31, 2020 | -66.41M |
December 31, 2019 | -74.46M |
December 31, 2018 | -66.57M |
Date | Value |
---|---|
December 31, 2017 | -57.52M |
December 31, 2016 | -18.70M |
December 31, 2015 | -10.12M |
December 31, 2014 | -48.51M |
December 31, 2013 | -24.27M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
-74.46M
Minimum
2019
127.12M
Maximum
2021
24.65M
Average
61.86M
Median
2023
Shareholders Equity (Annual) Benchmarks
Vanda Pharmaceuticals Inc | 544.91M |
BioCardia Inc | -1.603M |
Verrica Pharmaceuticals Inc | 19.76M |
Xeris Biopharma Holdings Inc | -6.782M |
Crinetics Pharmaceuticals Inc | 539.11M |